✦ LIBER ✦

KIT, NRAS, BRAF and PTEN mutations in a sample of Swedish patients with acral lentiginous melanoma

✍ Scribed by Zebary, Abdlsattar; Omholt, Katarina; Vassilaki, Ismini; Höiom, Veronica; Lindén, Diana; Viberg, Lisa; Kanter-Lewensohn, Lena; Johansson, Carolina Hertzman; Hansson, Johan

Book ID: 122877894
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 490 KB
Volume: 72
Category: Article
ISSN: 0923-1811
DOI: 10.1016/j.jdermsci.2013.07.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical characteristics and outcomes wi

Clinical characteristics and outcomes with specific BRAF and NRAS mutations in patients with metastatic melanoma

✍ Bucheit, Amanda D.; Syklawer, Erica; Jakob, John A.; Bassett, Roland L.; Curry, 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 203 KB

Correlation between KIT expression and K

Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type

✍ Torres-Cabala, Carlos A; Wang, Wei-Lien; Trent, Jonathan; Yang, Dan; Chen, Su; G 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 583 KB

Prevalence of BRAF V600E mutation in Chi

Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort

✍ Lu Si; Yan Kong; Xiaowei Xu; Keith T. Flaherty; Xinan Sheng; Chuanliang Cui; Zhi 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 235 KB

6096 POSTER FOLFOXIRI (Irinotecan, Oxali

6096 POSTER FOLFOXIRI (Irinotecan, Oxaliplatin, and Infusional 5FU/LV) in Combination With Panitumumab (P) in the First-line Treatment of Metastatic Colorectal Cancer (mCRC) Patients (pts) Selected for KRAS, BRAF, NRas and HRas Mutational Status – a Phase II Study by the G.O.N.O. Group

✍ Fornaro, L.; Loupakis, F.; Lonardi, S.; Masi, G.; Salvatore, L.; Cremolini, C.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB